Brief: Interpace Biosciences Q2 Revenue USD 9.232 Million
Aug 07 (Reuters) - Interpace Biosciences Q2 operating income USD -468 thousand. Q2 gross profit USD 5.276 million Q2 net income USD -640 thousand Q2 operating expenses USD 5.744 million
Aug 07 (Reuters) - Interpace Biosciences Q2 operating income USD -468 thousand. Q2 gross profit USD 5.276 million Q2 net income USD -640 thousand Q2 operating expenses USD 5.744 million